Sonoma Pharmaceuticals Shares Experience Dramatic Trading Session

Friday’s trading session witnessed significant volatility in Sonoma Pharmaceuticals stock, with the share price swinging more than 11% before ultimately settling at $3.99, representing a 4.72% gain for the day. The substantial price movements followed the company’s announcement of a new financing initiative that has divided investor opinion.

Despite market concerns about recent corporate actions, Sonoma’s fundamental business metrics demonstrate notable improvement. The company reported a 12% revenue growth for fiscal year 2025, while simultaneously reducing its net loss by 29%. Further encouraging news comes from a 17% decrease in EBITDA losses, indicating improving operational efficiency.

Equity Offering Sparks Investor Debate

On September 26, Sonoma revealed an arrangement with Ladenburg Thalmann that enables the company to raise up to $2.07 million through share... Read more...